Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Janet Wozniak, M.D.

Co-Author

This page shows the publications co-authored by Janet Wozniak and Timothy Wilens.
Connection Strength

1.989
  1. Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. J Child Adolesc Psychopharmacol. 2003; 13(4):495-505.
    View in: PubMed
    Score: 0.270
  2. Comorbidity of bipolar I disorder and conduct disorder: a familial risk analysis. Acta Psychiatr Scand. 2019 04; 139(4):361-368.
    View in: PubMed
    Score: 0.207
  3. Does the course of manic symptoms in pediatric bipolar disorder impact the course of conduct disorder? Findings from four prospective datasets. J Affect Disord. 2018 10 01; 238:244-249.
    View in: PubMed
    Score: 0.196
  4. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder. J Clin Psychiatry. 2016 Oct; 77(10):1420-1427.
    View in: PubMed
    Score: 0.175
  5. Are obstetrical, perinatal, and infantile difficulties associated with pediatric bipolar disorder? Bipolar Disord. 2012 Aug; 14(5):507-14.
    View in: PubMed
    Score: 0.129
  6. Examination of concordance between maternal and youth reports in the diagnosis of pediatric bipolar disorder. Bipolar Disord. 2009 May; 11(3):298-306.
    View in: PubMed
    Score: 0.105
  7. Risk of substance use disorders in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1380-6.
    View in: PubMed
    Score: 0.077
  8. Current concepts in the validity, diagnosis and treatment of paediatric bipolar disorder. Int J Neuropsychopharmacol. 2003 Sep; 6(3):293-300.
    View in: PubMed
    Score: 0.071
  9. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry. 2003 Jul 01; 54(1):1-8.
    View in: PubMed
    Score: 0.070
  10. High Correspondence Between Child Behavior Checklist Rule Breaking Behavior Scale with Conduct Disorder in Males and Females. Child Psychiatry Hum Dev. 2020 12; 51(6):978-985.
    View in: PubMed
    Score: 0.058
  11. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry. 2000 Sep 15; 48(6):458-66.
    View in: PubMed
    Score: 0.058
  12. Pediatric mania: a developmental subtype of bipolar disorder? Acta Neuropsychiatr. 2000 Sep; 12(3):131.
    View in: PubMed
    Score: 0.057
  13. Is bipolar disorder a risk for cigarette smoking in ADHD youth? Am J Addict. 2000; 9(3):187-95.
    View in: PubMed
    Score: 0.055
  14. Further Evidence of the Diagnostic Utility of the Child Behavior Checklist for Identifying Pediatric Bipolar I Disorder. Scand J Child Adolesc Psychiatr Psychol. 2019; 7(1):29-36.
    View in: PubMed
    Score: 0.053
  15. Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry. 1999 Jun; 38(6):680-5.
    View in: PubMed
    Score: 0.053
  16. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996 May; 35(5):599-605.
    View in: PubMed
    Score: 0.042
  17. Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 1995 Jan; 34(1):110-2.
    View in: PubMed
    Score: 0.039
  18. Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry. 2011 Aug; 50(8):807-17.e8.
    View in: PubMed
    Score: 0.030
  19. Impact of executive function deficits in youth with bipolar I disorder: a controlled study. Psychiatry Res. 2011 Mar 30; 186(1):58-64.
    View in: PubMed
    Score: 0.030
  20. Psychosocial functioning, familiality, and psychiatric comorbidity in bipolar youth with and without psychotic features. J Clin Psychiatry. 2011 Mar; 72(3):397-405.
    View in: PubMed
    Score: 0.030
  21. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Sep; 49(9):898-905.e3.
    View in: PubMed
    Score: 0.028
  22. Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):529-38.
    View in: PubMed
    Score: 0.027
  23. Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children. BMC Psychiatry. 2009 Feb 04; 9:2.
    View in: PubMed
    Score: 0.026
  24. Neurocognitive impairment in unaffected siblings of youth with bipolar disorder. Psychol Med. 2009 Aug; 39(8):1253-63.
    View in: PubMed
    Score: 0.025
  25. Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 05; 147B(7):1182-5.
    View in: PubMed
    Score: 0.025
  26. Parsing pediatric bipolar disorder from its associated comorbidity with the disruptive behavior disorders. Biol Psychiatry. 2001 Jun 15; 49(12):1062-70.
    View in: PubMed
    Score: 0.015
  27. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry. 1999 Aug; 38(8):960-5.
    View in: PubMed
    Score: 0.013
  28. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol. 1999; 9(4):247-56.
    View in: PubMed
    Score: 0.013
  29. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review. J Clin Psychiatry. 1998 Nov; 59(11):628-37; quiz 638.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.